4.8 Article

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial

Celine Gregoire et al.

Summary: BM-MSC therapy is safe and effective in treating severe COVID-19, with a higher survival rate compared to standard therapy. The use of BM-MSCs shows promise in controlling the immune-mediated inflammatory response associated with severe COVID-19, leading to improved outcomes.

FRONTIERS IN IMMUNOLOGY (2022)

Article Critical Care Medicine

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

Antoine Monsel et al.

Summary: The efficacy of UC-MSCs in patients with SARS-CoV-2-induced ARDS was assessed in this study. The results showed no significant difference in respiratory indicators between the UC-MSCs and placebo groups. The repeated UC-MSCs infusions did not lead to any serious adverse events during treatment or thereafter.

CRITICAL CARE (2022)

Review Hematology

Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?

Hamdan Hamdan et al.

Summary: MSCs possess immune regulatory and tissue regenerative properties, making them a potential therapy option for inflammatory and immune disorders, including acute GvHD. Preliminary data on using MSCs in COVID-19 patients with ARDS are emerging, suggesting a potential role for MSCs in innovative therapies for COVID-19.

BLOOD REVIEWS (2021)

Article Cell & Tissue Engineering

Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells

Richard Schaefer et al.

Summary: Studies have shown that MSCs carry receptors and are resistant to SARS-CoV-2 infection under steady-state and inflammatory conditions, with their immunomodulation potential remaining intact in the presence of the virus. This suggests the potential applicability of MSCs for COVID-19 treatment.

STEM CELL REPORTS (2021)

Article Respiratory System

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS

Johnatas Dutra Silva et al.

Summary: In acute respiratory distress syndrome (ARDS), mitochondrial dysfunction contributes to damage of the alveolar epithelial and endothelial barriers. Mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) can improve alveolar-capillary barrier integrity through mitochondrial transfer, restoring normal barrier properties and mitochondrial functions in a model of ARDS.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Giacomo Lanzoni et al.

Summary: The study confirmed safety of UC-MSC infusions in patients with COVID-19 ARDS. By reducing inflammatory cytokines, significant improvement was observed in UC-MSC-treated patients on day 6. The treatment markedly increased patient survival rate, SAE-free survival, and time to recovery.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells

Behnam Sadeghi et al.

Summary: The study showed that DSC therapy is safe and effective for patients with COVID-19-induced ARDS, improving oxygenation levels, decreasing inflammatory cytokine levels, and clearing pulmonary infiltrates.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Cell & Tissue Engineering

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

Seyed-Mohammad Reza Hashemian et al.

Summary: This study investigated the safety and effectiveness of multiple high-dose infusions of MSCs derived from placenta and umbilical cord in critically ill COVID-19-induced ARDS patients. Some patients showed significant improvement in respiratory distress and reduction in inflammatory markers after cell infusions.

STEM CELL RESEARCH & THERAPY (2021)

Article Multidisciplinary Sciences

Mesenchymal stromal cell apoptosis is required for their therapeutic function

Swee Heng Milon Pang et al.

Summary: Multipotent mesenchymal stromal cells (MSCs) have therapeutic benefits in preclinical models, with their apoptosis and immunosuppressive effects playing a crucial role in reducing disease severity and highlighting implications for cell-based therapies.

NATURE COMMUNICATIONS (2021)

Article Critical Care Medicine

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS

Helene Haeberle et al.

Summary: The study shows that MSC infusion is a safe treatment for severe COVID-19-induced ARDS, improving pulmonary function and overall outcome. Patients receiving MSC treatment had higher survival rates and lower lung injury scores compared to the control group.

JOURNAL OF INTENSIVE CARE MEDICINE (2021)

Article Oncology

Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial

Xiaowei Xu et al.

Summary: A study showed that using menstrual blood-derived MSCs to treat severe COVID-19 patients can reduce mortality, improve dyspnea, and increase oxygen saturation levels. This MSC-based therapy may be a promising alternative for treating severe COVID-19.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Medicine, Research & Experimental

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

Katherine D. Wick et al.

Summary: The study shows that treatment with mesenchymal stromal cells significantly reduced lung injury biomarkers in ARDS patients. Airspace biomarkers provide additional value for studying the pathogenesis, treatment effects, and outcomes of ARDS.

JCI INSIGHT (2021)

Article Cell & Tissue Engineering

Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial

Ismail Hadisoebroto Dilogo et al.

Summary: The use of umbilical cord mesenchymal stromal cells (UC-MSCs) as adjuvant treatment for critically ill patients with COVID-19 significantly increases the survival rate by modulating the immune system towards an anti-inflammatory state.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Cell & Tissue Engineering

Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey

Nesrin O. Ercelen et al.

Summary: The use of UC-MSC treatment for severe COVID-19 patients shows potential in improving survival rates, especially for patients who receive treatment before intubation. Higher weight and intubation status are risk factors that may impact the outcomes of COVID-19 patients. Further randomized studies are recommended to explore the detailed therapeutic mechanisms of MSCs in treating COVID-19.

STEM CELL REVIEWS AND REPORTS (2021)

Article Respiratory System

Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell Transplantation

Svetlana Herasevich et al.

Summary: The study identified several pretransplant risk factors for the development of ARDS after HCT, including decreased pulmonary function, abnormal laboratory indices, history of hospitalization, and specific drug exposure. This information could be valuable in predicting and preventing ARDS in HCT patients.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Review Medicine, Research & Experimental

Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics

Yingqian Zhu et al.

Summary: Aging frailty is a complex geriatric syndrome characterized by disruption of physiological homeostasis and declining health status. Factors such as genome instability, DNA damage, and stem cell exhaustion contribute to the development of frailty with advancing age. Effective interventions are needed to improve the health status of frail patients.

THERANOSTICS (2021)

Article Geriatrics & Gerontology

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19

Martin Iglesias et al.

Summary: The study evaluated the safety of administering ahUCMSC for patients with severe ARDS caused by COVID-19 and observed a continuous increase in PaO2/FiO2 post-infusion, contributing to the survival of patients.

AGING AND DISEASE (2021)

Article Biochemistry & Molecular Biology

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Lei Shi et al.

Summary: This study demonstrates that treatment with human umbilical cord-mesenchymal stem cells (UC-MSCs) can significantly improve lung lesions in COVID-19 patients and potentially have therapeutic effects in the 6-minute walk test. The incidence of adverse events was similar in both groups, indicating the good safety profile of UC-MSCs treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Immunology

COVID-19: Immunology and treatment options

Susanna Felsenstein et al.

CLINICAL IMMUNOLOGY (2020)

Article Cell & Tissue Engineering

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Lei Shu et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial

Fanping Meng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Cell & Tissue Engineering

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies

N. C. Nadia de Cassia Noronha et al.

STEM CELL RESEARCH & THERAPY (2019)

Article Immunology

Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells

Behnam Sadeghi et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide

Shouqin Zhang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Hematology

Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation

Wictor Aronsson-Kurttila et al.

ACTA HAEMATOLOGICA (2018)

Article Cell & Tissue Engineering

Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease

Olle Ringden et al.

STEM CELLS TRANSLATIONAL MEDICINE (2018)

Review Critical Care Medicine

Lessons to learn from epidemiologic studies in ARDS

Bairbre A. McNicholas et al.

CURRENT OPINION IN CRITICAL CARE (2018)

Review Respiratory System

Cell therapy in acute respiratory distress syndrome

Shahd Horie et al.

JOURNAL OF THORACIC DISEASE (2018)

Review Medicine, General & Internal

Acute Respiratory Distress Syndrome

B. Taylor Thompson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cell Biology

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation

Antonio Galleu et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Review Immunology

Cytokine storm and sepsis disease pathogenesis

Benjamin G. Chousterman et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Editorial Material Immunology

Cytokine storms in infectious diseases

John R. Teijaro

SEMINARS IN IMMUNOPATHOLOGY (2017)

Article Critical Care Medicine

Cell-based Therapy for Acute Respiratory Distress Syndrome Biology and Potential Therapeutic Value

John G. Laffey et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Cell & Tissue Engineering

The Orphan Receptor Tyrosine Kinase ROR2 Facilitates MSCs to Repair Lung Injury in ARDS Animal Model

Shi-xia Cai et al.

CELL TRANSPLANTATION (2016)

Article Critical Care Medicine

Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation

Hemang Yadav et al.

CRITICAL CARE MEDICINE (2016)

Article Biotechnology & Applied Microbiology

E-Prostanoid 2 Receptor Overexpression Promotes Mesenchymal Stem Cell Attenuated Lung Injury

Jibin Han et al.

HUMAN GENE THERAPY (2016)

Article Medicine, General & Internal

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Giacomo Bellani et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Cell & Tissue Engineering

Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells

Johannes Leibacher et al.

STEM CELL RESEARCH & THERAPY (2016)

Article Critical Care Medicine

Mesenchymal stem cells increase T-regulatory cells and improve healing following trauma and hemorrhagic shock

Amy V. Gore et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)

Article Critical Care Medicine

Mesenchymal stem cells increase T-regulatory cells and improve healing following trauma and hemorrhagic shock

Amy V. Gore et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)

Article Critical Care Medicine

Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome

Olle Ringdén

Lancet Respiratory Medicine (2015)

Article Critical Care Medicine

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

Jennifer G. Wilson et al.

LANCET RESPIRATORY MEDICINE (2015)

Article Medicine, General & Internal

Simvastatin in the Acute Respiratory Distress Syndrome

Daniel F. McAuley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Critical Care Medicine

Therapeutic Effects of Human Mesenchymal Stem Cells in Ex Vivo Human Lungs Injured with Live Bacteria

Jae W. Lee et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Biochemistry & Molecular Biology

Human Mesenchymal Stem Cells Overexpressing the IL-33 Antagonist Soluble IL-1 Receptor-Like-1 Attenuate Endotoxin-Induced Acute Lung Injury

Itziar Martinez-Gonzalez et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Sphingosine-1-Phosphate, FTY720, and Sphingosine-1-Phosphate Receptors in the Pathobiology of Acute Lung Injury

Viswanathan Natarajan et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Article Medicine, General & Internal

Prone Positioning in Severe Acute Respiratory Distress Syndrome

Claude Guerin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Cell & Tissue Engineering

Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Olle Ringden et al.

STEM CELLS (2013)

Article Physiology

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

Anna Krasnodembskaya et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Article Cell & Tissue Engineering

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

Kentaro Akiyama et al.

CELL STEM CELL (2012)

Article Immunology

Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro

H. Karlsson et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)

Article Critical Care Medicine

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

Niall D. Ferguson et al.

INTENSIVE CARE MEDICINE (2012)

Article Medicine, General & Internal

Acute Respiratory Distress Syndrome The Berlin Definition

V. Marco Ranieri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Cell & Tissue Engineering

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

Guido Moll et al.

STEM CELLS (2012)

Review Pathology

The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

Michael A. Matthay et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Article Cell & Tissue Engineering

Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation

Raine Tatara et al.

CYTOTHERAPY (2011)

Article Cell & Tissue Engineering

Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes

Felipe Saldanha-Araujo et al.

STEM CELL RESEARCH (2011)

Article Hematology

Influence of Pretransplantation Restrictive Lung Disease on Allogeneic Hematopoietic Cell Transplantation Outcomes

Alba Ramirez-Sarmiento et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)

Article Cardiac & Cardiovascular Systems

Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation

Konstantinos E. Hatzistergos et al.

CIRCULATION RESEARCH (2010)

Article Respiratory System

Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment

Elizabeth R. Johnson et al.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)

Article Medicine, General & Internal

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome.

Laurent Papazian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Cell & Tissue Engineering

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

Ruenn Chai Lai et al.

STEM CELL RESEARCH (2010)

Article Critical Care Medicine

Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time? A Systematic Review

Jason Phua et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Hematology

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Partow Kebriaei et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

Review Medicine, General & Internal

Immunomodulation by mesenchymal stem cells and clinical experience

K. Le Blanc et al.

JOURNAL OF INTERNAL MEDICINE (2007)

Article Immunology

Mesenchymal stem cells stimulate antibody secretion in human B cells

I. Rasmusson et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)

Article Infectious Diseases

Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation

Ulrica Forslow et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)

Article Hematology

Human mesenchymal stem cells modulate B-cell functions

A Corcione et al.

Article Cell & Tissue Engineering

Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons

Kirstin J. Beggs et al.

CELL TRANSPLANTATION (2006)

Article Medicine, General & Internal

Incidence and outcomes of acute lung injury

GD Rubenfeld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Cell & Tissue Engineering

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta

PS in't Anker et al.

STEM CELLS (2004)

Article Biochemistry & Molecular Biology

The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells

F Barry et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Critical Care Medicine

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

DC Angus et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)